PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
28-Mar-2024 APONTIS PHARMA expects profitable growth again in 2024 APONTIS PHARMA AG
28-Mar-2024 Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges Dermapharm Holding SE
28-Mar-2024 AEVIS VICTORIA SA (AEVS.SW) – Publication of the Annual Report 2023 AEVIS VICTORIA SA
28-Mar-2024 STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR STRATEC SE
27-Mar-2024 Top Eight Reasons to Attend Semantic Data 2024:  Taxonomy, Ontology, and Knowledge Graphs Conference  Henry Stewart
27-Mar-2024 Uni-Bio Science Group Announces 2023 Annual Results UNI-BIO SCIENCE GROUP LIMITED
27-Mar-2024 AstraZeneca CEO Sir Pascal Soriot Awarded Top Science Honour AstraZeneca
27-Mar-2024 Vidac Pharma receives Japanese Patent Office Notice of Allowance for VDA-1275 cancer drug candidate Vidac Pharma
27-Mar-2024 Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China’s NMPA Santhera Pharmaceuticals
27-Mar-2024 Heidelberg Pharma granted orphan drug designation by FDA for its proprietary ATAC candidate HDP-101 Heidelberg Pharma
27-Mar-2024 Abilify Maintena® 960 mg (aripiprazole) approved in the EU as the first once-every-two-months long-acting injectable for the maintenance treatment of schizophrenia Otsuka Pharmaceutical
27-Mar-2024 Heidelberg Pharma granted orphan drug designation by FDA for its proprietary ATAC candidate HDP-101 Heidelberg Pharma AG
27-Mar-2024 Medios achieves double-digit growth in 2023 – Positive outlook for 2024 Medios AG
27-Mar-2024 NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System Olympus
27-Mar-2024 RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting Relief Therapeutics Holding SA
27-Mar-2024 Modern Dental Group Announces 2023 Annual Results - Record High Revenue, EBITDA and Net Profit, Number of Cases Surpassing 2 Million Modern Dental Group Limited
26-Mar-2024 Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. Sartorius Stedim Biotech SA
26-Mar-2024 ERFOLGE VON DEFENCE BEI SEINEM ACCUTOX®-ARM(TM)-VAKZIN ZUR KREBSBEKÄMPFUNG FÜHREN ZUR ENTWICKLUNG EINES WIRKUNGSVOLLEN ARM-002(TM)-KREBSIMPFSTOFFS DER ZWEITEN GENERATION Defence Therapeutics Inc.
26-Mar-2024 MEDICLIN achieves consolidated Group sales of EUR 730.1 million in 2023 - outlook for 2024 is positive MEDICLIN AG
26-Mar-2024 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG